Furthermore, its interpretability enables the identification of critical cancer-associated genes, with experimental validation uncovering three novel genes—PCDHA10, PRICKLE2, and PRTG—that exhibit inhibitory effects on breast cancer cell proliferation and migration. Here, PRICKLE2 is linked to breast carcinoma.